Article
Schering-Plough Establishes Brazilian Subsidiary
Author(s):
Schering-Plough (Kenilworth, NJ, www.sch-plough.com) will establish Schering-Plough Produtos Farmaceuticos Limitada in Sao Paulo, Brazil, to market its core products.
Schering-Plough (Kenilworth, NJ, www.sch-plough.com) will establish Schering-Plough Produtos Farmaceuticos Limitada in Sao Paulo, Brazil, to market its core products. The company will also restructure its agreement (originally formed in 1991) with Brazil-based drug manufacturer Mantefarma, now to be known as Mantecorp, in an effort to increase Schering’s presence in Latin America. Schering-Plough Produtos Farmaceuticos Limitada will commercialize specialty care products, including hepatitis C treatment PegIntron (peginterferon alfa-2b) and cancer-fighting drugs Temodal (temozolomide) and Caelyx (pegylated liposomal doxorubicin HCI).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
